1-2 of 2
Mercedes Nadal-Serrano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer

Santiago Duro-Sánchez, Mercedes Nadal-Serrano, Marta Lalinde-Gutiérrez, Enrique Javier Arenas, Cristina Bernadó Morales, Beatriz Morancho, Marta Escorihuela, Sandra Pérez-Ramos, Santiago Escrivá-de-Romaní, Lucía Gandullo-Sánchez, Atanasio Pandiella, Anna Esteve-Codina, Verónica Rodilla, Fred A. Dijcks, Wim H.A. Dokter, Javier Cortés, Cristina Saura, Joaquín Arribas
Journal: Cancer Research
Cancer Res (2022) 82 (24): 4670–4679.
https://doi.org/10.1158/0008-5472.CAN-22-0787
Published: 16 December 2022
View articletitled, Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer
Open the PDF for Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody–Drug Conjugates in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity

Carla Ríos-Luci, Sara García-Alonso, Elena Díaz-Rodríguez, Mercedes Nadal-Serrano, Joaquín Arribas, Alberto Ocaña, Atanasio Pandiella
Journal: Cancer Research
Cancer Res (2017) 77 (17): 4639–4651.
https://doi.org/10.1158/0008-5472.CAN-16-3127
Published: 31 August 2017
View articletitled, Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity
Open the PDF for Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity in another window
Includes: Multimedia, Supplementary data